Accord Healthcare has been nominated as a finalist in seven categories in the Global Generics & Biosimilars 2022 Awards.
Paul Tredwell, EVP EMENA says: “To be finalists in several categories at such a highly respected awards event is a testament to our people whose loyalty, drive and dedication to the healthcare industry go above and beyond our purpose.
“We look forward to the awards evening in November and congratulate all the other finalists.”
Accord Healthcare are finalists in the following categories:
- Company of the Year
- Company of the Year, EMEA Region
- Biosimilar Initiative of the Year
- Business Development of the Year
- Value Added Medicine Initiative of the Year
- Corporate Social Responsibility (CSR) Initiative of the Year
- Regulatory Achievement of the Year